Overview

A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954

Status:
Completed
Trial end date:
2019-08-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of varying degrees of renal function on the PK of TAK-954 following single-dose IV administration and to investigate the impact of hemodialysis on the PK of single IV doses of TAK-954.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda